159 related articles for article (PubMed ID: 23425266)
1. European perspective on biosimilars.
Wadhwa M; Thorpe R
Bioanalysis; 2013 Mar; 5(5):521-4. PubMed ID: 23425266
[No Abstract] [Full Text] [Related]
2. Analytical and bioanalytical assay challenges to support comparability studies for biosimilar drug development.
Cai XY; Wake A; Gouty D
Bioanalysis; 2013 Mar; 5(5):517-20. PubMed ID: 23425265
[No Abstract] [Full Text] [Related]
3. Clinical development of biosimilars: an evolving landscape.
Subramanyam M
Bioanalysis; 2013 Mar; 5(5):575-86. PubMed ID: 23425273
[TBL] [Abstract][Full Text] [Related]
4. Mini Focus: bioanalysis of biosimilars.
Amaravadi L; Marini J
Bioanalysis; 2013 Mar; 5(5):515-6. PubMed ID: 23425264
[No Abstract] [Full Text] [Related]
5. A wide angle view of biosimilars from a bioanalytical perspective.
Oldfield P
Bioanalysis; 2013 Mar; 5(5):533-5. PubMed ID: 23425269
[No Abstract] [Full Text] [Related]
6. Nonclinical development of a biosimilar: the current landscape.
O'Connor A; Rogge M
Bioanalysis; 2013 Mar; 5(5):537-44. PubMed ID: 23425270
[TBL] [Abstract][Full Text] [Related]
7. Biosimilars in rheumatology: the wind of change.
Schneider CK
Ann Rheum Dis; 2013 Mar; 72(3):315-8. PubMed ID: 23390018
[No Abstract] [Full Text] [Related]
8. Biosimilars take center stage.
Adams KT
Manag Care; 2014 Apr; 23(4):44-6. PubMed ID: 24864533
[No Abstract] [Full Text] [Related]
9. A consistency approach for evaluation of biosimilar products.
Tsou HH; Chang WJ; Hwang WS; Lai YH
J Biopharm Stat; 2013; 23(5):1054-66. PubMed ID: 23957515
[TBL] [Abstract][Full Text] [Related]
10. Epoetin biosimilars in Europe: five years on.
Mikhail A; Farouk M
Adv Ther; 2013 Jan; 30(1):28-40. PubMed ID: 23242745
[TBL] [Abstract][Full Text] [Related]
11. Biosimilar safety considerations in clinical practice.
Choy E; Jacobs IA
Semin Oncol; 2014 Feb; 41 Suppl 1():S3-14. PubMed ID: 24560025
[TBL] [Abstract][Full Text] [Related]
12. Conference report: 6th GCC focus on LBA: critical reagents, positive controls and reference standards; specificity for endogenous compounds; biomarkers; biosimilars.
Nicholson R; Lowes S; Caturla MC; Safavi A; Mamelak D; Islam R; Allinson J; Gouty D; Khan M; Lelacheur R; Shoup R; Martinez S; Dumont I; Zimmer J; Steffen R; Petrilla J; Awaiye K; Sheldon C; Turk D; Fast D; Kamerud J; Dinan A; Lin ZJ; Garofolo W; Tang D; Wright L; Lin J; Yamashita Y; Liu Y; Xu A; Hayes R; Bouhajib M; Levesque A; Gagnon-Carignan S; Harman J; Warren M; Karnik S; Cojocaru L; Reuschel S; Gonzalez P; Fatmi S; Vija J; Rock M; Malone M; Nowatzke W; Fang X
Bioanalysis; 2012 Oct; 4(19):2335-42. PubMed ID: 23088460
[No Abstract] [Full Text] [Related]
13. The comparability conundrum: biosimilars in the United States, Europe and Canada.
Courage N; Parsons A
Food Drug Law J; 2011; 66(2):203-24, i-ii. PubMed ID: 24505840
[TBL] [Abstract][Full Text] [Related]
14. [Biosimilars--opportunity or threat?].
Swierkot J
Wiad Lek; 2013; 66(2 Pt 2):200-5. PubMed ID: 25775818
[TBL] [Abstract][Full Text] [Related]
15. Key considerations in the preclinical development of biosimilars.
Bui LA; Hurst S; Finch GL; Ingram B; Jacobs IA; Kirchhoff CF; Ng CK; Ryan AM
Drug Discov Today; 2015 May; 20 Suppl 1():3-15. PubMed ID: 25912284
[TBL] [Abstract][Full Text] [Related]
16. Conference Report: Bioanalysis-related topics presented at the International Conference and Exhibition on Biowaivers and Biosimilars.
Colletti KS
Bioanalysis; 2013 Mar; 5(5):529-31. PubMed ID: 23425268
[TBL] [Abstract][Full Text] [Related]
17. Differences in bioanalytical method validation for biologically derived macromolecules (biosimilars) compared with small molecules (generics).
Oldfield P
Bioanalysis; 2011 Jul; 3(14):1551-3. PubMed ID: 21756087
[No Abstract] [Full Text] [Related]
18. Challenges in bioanalytical assays for biosimilars.
Wang X; Chen L
Bioanalysis; 2014 Aug; 6(16):2111-3. PubMed ID: 25331854
[No Abstract] [Full Text] [Related]
19. Biosimilars: State of Clinical and Regulatory Science.
Klein AV; Wang J; Feagan BG; Omoto M
J Pharm Pharm Sci; 2017; 20(1):332-348. PubMed ID: 29145936
[TBL] [Abstract][Full Text] [Related]
20. Competition in the Age of Biosimilars.
Chandra A; Vanderpuye-Orgle J
JAMA; 2015 Jul; 314(3):225-6. PubMed ID: 26197179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
